SS
Satendra Singh
About Satendra Singh
Data last updated:
Satendra Singh is a Director at Brahmani Infrahomes Private Limited (since 2020), Director at Brahmani Realestate Private Limited (since 2020) and Director at Brahmani Infrahousing Private Limited (since 2020), and holds 1 more current directorship. The companies operate in Construction and Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Mar 2020 | 2016 | Active | ||
| Director | 01 Mar 2020 | 2016 | Active | ||
| Director | 01 Mar 2020 | 2016 | Active | ||
| Director | 20 Feb 2020 | 2020 | Active |
Board colleagues of Satendra Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anurag Bhardwaj | 08848464 | Brahmani Infrahomes Private Limited , Brahmani Realestate Private Limited and 1 more | Director |
| Ravi Yadav | 08335760 | Brahmani Infrahomes Private Limited , Brahmani Realestate Private Limited and 1 more | Director |
| Mohd Atique Ansari | 08706308 | Elius Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satendra Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satendra Singh
Satendra Singh currently holds 4 directorships: Brahmani Infrahomes Private Limited (Director, since 01 Mar 2020); Brahmani Realestate Private Limited (Director, since 01 Mar 2020); Brahmani Infrahousing Private Limited (Director, since 01 Mar 2020); Elius Pharma Private Limited (Director, since 20 Feb 2020).
Satendra Singh was first appointed on 20 Feb 2020 as Director at Elius Pharma Private Limited.
The current boards of Satendra Singh's companies include Anurag Bhardwaj (Brahmani Infrahomes Private Limited), Ravi Yadav (Brahmani Infrahomes Private Limited), Mohd Atique Ansari (Elius Pharma Private Limited).